The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ANGIOMET: Analysis of the correlations between angiogenic markers and outcome in patients (p) with advanced nonsquamous NSCLC (NS-NSCLC) treated with carboplatin, paclitaxel, and bevacizumab (CPB).
Bartomeu Massuti
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche
Eloisa Jantus-Lewintre
Research Funding - Roche
Jose Luis Gonzalez Arriba
Consultant or Advisory Role - Roche
Delvys Rodriguez Abreu
No relevant relationships to disclose
Oscar Juan
No relevant relationships to disclose
Manuel Domine
Consultant or Advisory Role - Roche
Mariano Provencio
No relevant relationships to disclose
Javier Garde
No relevant relationships to disclose
Ramon Garcia Gomez
No relevant relationships to disclose
Inmaculada Maestu
No relevant relationships to disclose
Ramon Maria Perez Carrion
No relevant relationships to disclose
Angel Artal
No relevant relationships to disclose
Christian Diego Rolfo
No relevant relationships to disclose
Josefa Terrasa
No relevant relationships to disclose
Juana Oramas
No relevant relationships to disclose
Ramon De Las Penas
No relevant relationships to disclose
Maria Sanchez Ronco
No relevant relationships to disclose
Javier De Castro
Consultant or Advisory Role - Roche/Genentech
Rafael Rosell
Consultant or Advisory Role - Roche
Research Funding - Roche/Genentech
Carlos Camps
Consultant or Advisory Role - Roche
Research Funding - Roche